PolarityTE Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$17.8M
Lead Investor(s):Cantor Fitzgerald

Industry Ranking

Estimated Revenue & Financials

  • PolarityTE's estimated annual revenue is currently $1.6M per year.
  • PolarityTE received $17.8M in venture funding in September 2017.
  • PolarityTE's estimated revenue per employee is $16,281
  • PolarityTE's total funding is $17.8M.

Employee Data

  • PolarityTE has 96 Employees.
  • PolarityTE grew their employee count by -36% last year.
  • PolarityTE currently has 4 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
Missing a competitor? Contribute!?

PolarityTE (NASDAQ: COOL) is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. The PolarityTE platform technology begins with a small piece of the patient's own, or autologous, healthy tissue, rather than artificially manipulated individual cells. From this small piece of healthy autologous tissue, the company creates an easily deployable, dynamic and self-propagating product designed to enhance and stimulate the patient's own cells to regenerate the target tissues. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures with the patient's own tissue and uses the patient's own body to support the regenerative process to create the same tissue from which it was derived. PolarityTE's innovative method is intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing.



Number of Employees


Revenue (est)


Current Jobs


Employee Growth %


Total Funding







PolarityTE News

09/09/2019 - SkinTE Data to be Presented at the American Society of ...

SALT LAKE CITY, Sept. 9, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing ...

08/16/2019 - PolarityTE to Present at Military Health System Research ...

SALT LAKE CITY, Aug. 16, 2019 /PRNewswire/ -- PolarityTE, Inc. (NASDAQ: PTE), a biotechnology company developing and commercializing ...

08/28/2019 - PolarityTE to Attend HC Wainwright 21st Annual Healthcare ...

SALT LAKE CITY, Aug. 28, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing

PolarityTE Funding

DateAmountRoundLead InvestorsReference
2017-09-22$17.8MUndisclosedCantor FitzgeraldArticle

PolarityTE Executive Hires

2017-03-01Burke PowersVice President of Product DevelopmentArticle
2017-10-09Maurice NahabedianChief Surgical OfficerArticle
2018-09-27Alain AdamVice President, SalesArticle
2018-10-22Sharon WhalenVice President of Market AccessArticle
2018-11-28Matt KempChief Commercial OfficerArticle
2019-01-08Jon BurrowsPres Contract Services/SVP Corporate DevelopmentArticle
2019-01-30David SeaburgPresident of Corporate DevelopmentArticle
2019-04-01Richard HagueCOOArticle